Philips Respironics recalled 13,811 ventilators the company reworked or replaced after it pulled millions of them off the market in summer 2021. The devices — Trilogy 100, Trilogy 200, and Garbin Plus ...
The U.S. Food and Drug Administration (FDA) has ordered a software recall for a type of ventilator, for fear of "serious injuries or death." The ventilators—the Philips Respironics, Inc. Trilogy EVO, ...
More than a year into the repair-and-replace program for the 5.5 million CPAP and BiPAP machines and other ventilators recalled by Philips since June 2021, the Dutch devicemaker has identified a pair ...
The U.S. Food and Drug Administration (FDA) said on Thursday that it has classified the recall of certain reworked Philips (NYSE:PHG) ventilators as the most serious type, class 1, because their use ...
In November, about a year and a half into its recall of 5.5 million respiratory devices—and well into a subsequent repair-and-replace program for the affected devices—Philips disclosed that it had ...
(RTTNews) - Philips Respironics, affiliated to Dutch consumer electronics giant, announced additional usage instructions for Trilogy Evo Ventilators related to use of in-line nebulizers. The company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results